Request ... a quotation or more information.

*  Consistent with ICH Q7, Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients, August, 2001.

May 1, 2009 -- In direct response to user requests and unique application needs, we have added more vial options for ¹⁷⁷Lutetium and ¹¹¹Indium. As is already the case with ⁹⁰Yttrium Chloride, you can now choose the shipping vial most suitable to your application when placing your order.

March 1, 2009 -- The pre-printed wording on the ⁹⁰Yttrium and ¹⁷⁷Lutetium vial has changed to:
For laboratory use only.  A research chemical for research and investigational use only.

We felt that this statement more accurately reflects the wide range of applications of our customers. The label change does not reflect a change to the product itself.

March 1, 2009 -- The pre-printed wording on the ⁹⁰Yttrium and ¹⁷⁷Lutetium vial has changed to:
For laboratory use only.  A research chemical for research and investigational use only.

We felt that this statement more accurately reflects the wide range of applications of our customers. The label change does not reflect a change to the product itself.

May 1, 2009 -- In direct response to user requests and unique application needs, we have added more vial options for ¹⁷⁷Lutetium and ¹¹¹Indium. As is already the case with ⁹⁰Yttrium Chloride, you can now choose the shipping vial most suitable to your application when placing your order.

March 1, 2009 -- ¹¹¹Indium Chloride (radiochemical grade) Lot Specific Data Sheets will now also include Chemical Purity data and the Radiochemical Concentration at Calibration value. These additional values are a result of requests from our customers and we hope you will find this additional information helpful.

January 1, 2009 -- We are now custom dispensing all ¹¹¹Indium Chloride (radiochemical grade) orders. Orders can be placed in mCi increments above the 2mCi minimum; and the day of calibration can be specified for the order.

The research is a complementary reflection on our manufacturing and quality standards. PerkinElmer’s reproducible Y-90 production methods, established manufacturing facilities, and confirmatory release testing provide customers with confidence that metals contamination in Y-90 shipments will not be a concern. 

Studies with Lu-177 are planned for early 2010.

Tyramide Signal Amplification (TSA™) is a patented technology that amplifies signals in standard IHC protocols.

The addition of TSA to your current IHC protocol may reveal localized targets previously undetectable - without loss of resolution and with no increase in background.

The use of TSA may also allow you to reduce the amount of primary antibody, eliminate PCR, and/or perform multi-target detection. TSA methods are compatible with chromogenic and fluorescent detection.

Read ... about TSA technology and kits.
View and download ... a bibliography of TSA Applications.

... for radiometric immuno assays (RIA), chromium release studies, positron emission tomography (PET), research among other gamma nucleotide applications.

Updated to feature Windows® XP software, touch-screen operation, easy networking capability and USB ports for simple data transfer. The WIZARD2 Automatic Gamma Counters now features a user-friendly interface system with a package of technology advancements for academic, nuclear medicine and pharmaceutical research. Read more.

...for TLC of radiopharmaceuticals, filmless autoradiography of tissue sections, and more.

High efficiency storage phosphor screens replace autoradiography film to capture and store the activity of samples, which are exposed in common film cassettes. Cyclone Plus is designed with state-of-the-art confocal optics and a helical scanning system. Read more.

Morphological and functional Integration: a course on PET and CT fusion imaging.
20-23 January, 2010
Rome, Italy

15th European Symposium on Radiopharmacy and Radiopharmaceuticals
8-11 April, 2010
Edinburgh, Scotland

48th Annual Congress of the German Association of Nuclear Medicine
21-24 April, 2010
Leipzig, Germany

28th Annual Meeting British Nuclear Medicine Society
26-28 April, 2010
Harrogate, United Kingdom

PerkinElmer’s recent investment in radiolabeling and bead-based assay technologies furthers our interest in products, infrastructure, and support of technologies for the detection and screening of potential new drugs.

PerkinElmer purchased the assets of GE Healthcare’s 3H and 14C Catalog Radiochemicals, Scintillation Proximity Assay (SPA) reagents and Cytostar-T plate product lines in September 2009.

Incorporation of these reagents and technologies will strengthen our industry-leading GPCR and Kinase research product lines, and complement our HTS and Research Reagent solutions.

This purchase reinforces PerkinElmer's continued position as the leading company in HTS radiochemicals and related instruments, as we remain committed to supporting critical radiochemicals-based research.

Every three months, our email newsletter contains information we hope you will find useful and timely.

To guarantee delivery, we recommend that you subscribe...

If you subscribed previously, Thank You! If you can't remember, it's okay to subscribe again.

Do not hesitate to contact me
with any comments.

PerkinElmer Radiation Safety Information
  |   Guide to Safe Handling of Radioactive Materials   |  

PerkinElmer Product Guides and Information
  |   Radiometric Reagents Guide   |   Storage Phosphor Imager   |   Gamma Counters   |   Radiochemical Portfolio   |  

PerkinElmer: About Us.
  |   Read about PerkinElmer and children's product safety   |  
  |   About PerkinElmer   |   Corporate and Product News from our Press Room   |  

Linda joined PerkinElmer NEN Radiochemicals in June, 2000 and has been a full time customer care specialist in the Brussels Center since January of 2001.

Linda added Radiotherapeutics to her responsibilities in 2003 - preparing quotations, entering orders, and following up on delivery.

In her free time, Linda enjoys gardening and family time - especially with her new grandson. Congratulations, Linda!

Pat spent her childhood in the state of Maine in the north eastern part of the USA. She relocated to Massachusetts to pursue her B.A. and M.A. in Chemistry from Regis College and Northeastern University in the Boston area.

Pat has spent her entire professional career at PerkinElmer, hired by New England Nuclear as an R & D chemist for new product development in iodinated products.

After spending 20 years in various R & D initiatives at PerkinElmer, Pat moved her career path to the business side as a product manager with various product lines.

Today, Pat manages the team of product managers responsible for all of the NEN Radiochemicals business at PerkinElmer, including our Radiotherapeutics product line.

In her free time Pat likes to read, enjoy movies, and spend time at the beach.

Bob was born in Massachusetts, USA. He graduated from Fitchburg State College with a degree in Biology.

Bob is a lifelong New England Nuclear (NEN) / PerkinElmer employee. After graduation, Bob joined NEN as a protein chemist working in the Life Science product line.

After spending several years working at the bench, Bob accepted a position in management leading several manufacturing groups. Most recently, he has managed the growing Radiotherapeutics manufacturing group.

In his free time, Bob enjoys spending time with family, traveling to tropical islands, and home improvement projects.

Like Bob, Lorraine was also born in Massachusetts, USA.  She graduated from Emmanuel College in Boston with a degree in Chemistry. She went on to receive her Master’s Degree in Physical Chemistry from Boston College. 

Lorraine is also a lifelong NEN / PerkinElmer employee. She joined NEN in 1970 as a chemist specializing in radioanalytics.  In 1982, after NEN was purchased by duPont, she changed career paths and worked in molecular biology for over 20 years. 

During that time NEN was acquired by PerkinElmer, and in 2003 she returned to chemistry, joining the Radiotherapeutics Group as a Quality Control specialist. 

A busy traveler, Lorraine has visited more than forty countries – probably including yours!  She also enjoys classical music, visiting art museums and cooking.

Paola was born in Lecco, Italy and graduated from the University of Milan in Molecular Biology. After graduation, she worked in a research cancer institute in Milan on differential gene expression.

Paola entered the commercial market as a technical specialist for life science reagents. She joined PerkinElmer in September 2005. Recently, she’s been dividing her time: responsible full-time for reagents sales in Italy, and part-time to the specialized field of radiotherapeutics.

In January 2009, with great pleasure, Paola accepted a full-time position as European Radiotherapeutics Specialist.

In her free time Paola enjoys traveling and good cuisine.

Lori was born and educated in Delaware, US, a northern coastal state known for its chemical companies. She attended the University of Delaware majoring in Biology.

Lori began her professional career at duPont working in Toxicology and Engineering research.

Soon thereafter, she found an interest in Sales, representing DuPont NEN Radiochemicals, and subsequently with Registered Pharmaceuticals and PerkinElmer NEN Radiochemicals.

Since 2002, Lori has had the pleasure of representing the PerkinElmer Radiotherapeutics portfolio and traveling around the world to visit many of our Nuclear Medicine customers and their facilities.

In her free time Lori enjoys time with family, painting and gardening.